Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
Biochemical Society Transactions|March 21, 2006
Insulin secretion in health and disease: genomics, proteomics and single vesicle dynamicsG A Rutter, A Varadi, T Tsuboi, et al.Plos Computational Biology|April 18, 2013
Formation of raft-like assemblies within clusters of influenza hemagglutinin observed by MD simulationsDaniel L Parton, Alex Tek, Marc Baaden, et al.JAMA|January 1, 1988
Induction of immune tolerance to factor VIII in hemophiliacs with inhibitorsN P Ewing, N L Sanders, S L Dietrich, et al.The Journal of Biological Chemistry|August 5, 1988
Molecular defect in factor IXBm Lake Elsinore. Substitution of Ala390 by Val in the catalytic domainS G Spitzer, U R Pendurthi, C K Kasper, et al.American Journal of Hematology|July 1, 1993
Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sourcesJ B Lefkowitz, D M Monroe, C K Kasper, et al.The Journal of Clinical Investigation|January 1, 1985
Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic siteP Usharani, B J Warn-Cramer, C K Kasper, et al.Journal of Perinatology : Official Journal of the California Perinatal Association|December 5, 2008
Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot studyM DeCastro, N El-Khoury, L Parton, et al.Pediatric Research|August 1, 1988
Combined effects of corticosteroid, thyroid hormones, and beta-agonist on surfactant, pulmonary mechanics, and beta-receptor binding in fetal lamb lungD Warburton, L Parton, S Buckley, et al.Thrombosis and Haemostasis|February 23, 1981
Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factorB Osterud, C K Kasper, K K Lavine, et al.Blood|February 15, 1989
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)P H Reitsma, T Mandalaki, C K Kasper, et al.Pageof 12